Loading resource…

null
In the past three years, significant recommendations for managing systemic sclerosis have been published, reflecting a robust methodology aligned with other rheumatic conditions. The document discusses the management of interstitial lung disease (ILD), a common complication of SSc, and highlights advances in treatment and evidence-based recommendations. It also addresses the differences in methodology and scope between various organizations involved in guideline development.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

2025 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) GUIDELINE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

EVIDENCE-BASED GUIDELINE FOR THE DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Same clinical topic · Rheumatology

KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS
Same clinical topic · Rheumatology

2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Same clinical topic · Rheumatology

2026 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Axial Spondyloarthritis in Adults and Children/Adolescents
Same clinical topic · Rheumatology

Approach to a patient with joint pain
Same specialty · Rheumatology

Current Diagnosis & Treatment Rheumatology 4th Edition 2021
Same specialty · Rheumatology

Rheumatology secrets fourth edition
Same specialty · Rheumatology

PassMedicine 2025 Rheumatology part 2
Same specialty · Rheumatology